NO174474C - FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650 - Google Patents

FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650

Info

Publication number
NO174474C
NO174474C NO891462A NO891462A NO174474C NO 174474 C NO174474 C NO 174474C NO 891462 A NO891462 A NO 891462A NO 891462 A NO891462 A NO 891462A NO 174474 C NO174474 C NO 174474C
Authority
NO
Norway
Prior art keywords
streptoalloteichus
atcc
preparation
well
kedarcidin
Prior art date
Application number
NO891462A
Other languages
English (en)
Other versions
NO174474B (no
NO891462L (no
NO891462D0 (no
Inventor
Sandra June Hofstead
James Andrew Matson
Kin Sing Lam
Salvator Forenza
James Allen Bush
Koji Tomita
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO891462D0 publication Critical patent/NO891462D0/no
Publication of NO891462L publication Critical patent/NO891462L/no
Publication of NO174474B publication Critical patent/NO174474B/no
Publication of NO174474C publication Critical patent/NO174474C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO891462A 1988-04-12 1989-04-10 FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650 NO174474C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (4)

Publication Number Publication Date
NO891462D0 NO891462D0 (no) 1989-04-10
NO891462L NO891462L (no) 1989-10-13
NO174474B NO174474B (no) 1994-01-31
NO174474C true NO174474C (no) 1998-06-09

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891462A NO174474C (no) 1988-04-12 1989-04-10 FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650

Country Status (24)

Country Link
US (1) US5001112A (no)
EP (1) EP0337430B1 (no)
JP (1) JP2850132B2 (no)
KR (1) KR970010137B1 (no)
CN (1) CN1034589C (no)
AT (1) ATE101653T1 (no)
AU (1) AU623641B2 (no)
CA (1) CA1338262C (no)
CY (1) CY1849A (no)
DE (1) DE68913063T2 (no)
DK (1) DK174751B1 (no)
ES (1) ES2061760T3 (no)
FI (1) FI93969C (no)
HK (1) HK83195A (no)
HU (1) HU201119B (no)
IE (1) IE62912B1 (no)
IL (1) IL89896A0 (no)
MY (1) MY105842A (no)
NO (1) NO174474C (no)
NZ (1) NZ228672A (no)
PL (1) PL161004B1 (no)
PT (1) PT90252B (no)
SG (1) SG30654G (no)
YU (1) YU73989A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
HUE029265T2 (en) * 2008-10-27 2017-02-28 Glaxosmithkline Biologicals Sa Method of purifying carbohydrates from the group streptococci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (no) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
DE68913063D1 (de) 1994-03-24
JP2850132B2 (ja) 1999-01-27
JPH01317396A (ja) 1989-12-22
DK174751B1 (da) 2003-10-20
FI93969B (fi) 1995-03-15
HK83195A (en) 1995-06-01
ES2061760T3 (es) 1994-12-16
PT90252B (pt) 1994-07-29
IE62912B1 (en) 1995-03-08
PL161004B1 (pl) 1993-05-31
HUT50880A (en) 1990-03-28
PL278782A1 (en) 1989-12-27
CY1849A (en) 1996-03-08
EP0337430A3 (en) 1991-07-24
NO174474B (no) 1994-01-31
AU3272889A (en) 1989-10-19
EP0337430A2 (en) 1989-10-18
IE891157L (en) 1989-10-12
CA1338262C (en) 1996-04-23
US5001112A (en) 1991-03-19
FI93969C (fi) 1995-06-26
FI891710A0 (fi) 1989-04-11
DK173589A (da) 1989-10-13
SG30654G (en) 1995-09-01
FI891710A (fi) 1989-10-13
MY105842A (en) 1995-01-30
CN1034589C (zh) 1997-04-16
CN1037735A (zh) 1989-12-06
DE68913063T2 (de) 1994-06-09
NO891462L (no) 1989-10-13
AU623641B2 (en) 1992-05-21
DK173589D0 (da) 1989-04-11
KR900016469A (ko) 1990-11-13
KR970010137B1 (ko) 1997-06-21
NO891462D0 (no) 1989-04-10
ATE101653T1 (de) 1994-03-15
EP0337430B1 (en) 1994-02-16
NZ228672A (en) 1990-07-26
YU73989A (en) 1991-04-30
IL89896A0 (en) 1989-12-15
PT90252A (pt) 1989-11-10
HU201119B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
AU3444989A (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
AU7450887A (en) Novel human TNF polypeptide mutants and DNAs encoding said mutants
AU5245186A (en) Oxidation resistant mutant proteins
ZA856194B (en) Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby
AU4629885A (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
DK0409098T3 (da) Ekspression og secernering af moden human beta-interleukin-1 i Bacillus subtilis samt midler og fremgangsmåder til opnåelse heraf
DE58908428D1 (de) Sekretormutante von Escherichia coli.
NO174474C (no) FremgangsmÕte til fremstilling av et antibiotisk kedarcidin, samt en biologisk ren kultur av streptoalloteichus L585-6, ATCC 53650
EP0249412A3 (en) C-terminal alpha-amidating enzyme and process for production and use thereof
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
AU5024490A (en) Method of recovering purified epi protein from a solution especially a fermentation solution
EP0322717A3 (en) Dactylocycline a and dactylocycline b

Legal Events

Date Code Title Description
MK1K Patent expired